NIH-funded research R01 grant

Sleep medicines and interactions in children and teens with ADHD

Official title: ADHD and Sleep: Evaluating the Impact of Drug-Drug and Drug-Disease Interactions to Inform Care

Funded at Rutgers Biomedical and Health Sciences · NIH-11322682 · Data updated 2026-11-12

Looks at how common sleep medicines and ADHD treatments interact and what that means for children's and teens' sleep and safety.

More ADHD research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startMay 1, 2025
Project endFebruary 28, 2030
Funding year2026
Award (this year)$643,348
NIH project number5R01MH135875-02
Project IDNIH-11322682 on NIH RePORTER

Who could benefit from this research

Could help

Children and adolescents with ADHD who have sleep problems and who are taking or considering stimulant medications or commonly prescribed sleep medicines.

Less likely to help

Adults without ADHD, young people who do not take sleep medicines or stimulants, or those outside the study's age range are unlikely to directly benefit from this project.

What this research studies

From my point of view, researchers will follow children and adolescents with ADHD who have sleep problems and who are prescribed sleep medicines or stimulants. They will analyze health records and prescription data to check links between five commonly used sleep drugs (trazodone, benzodiazepines, nonbenzodiazepine hypnotics, alpha-blockers, and hydroxyzine) and serious outcomes like overdose, heart problems, suicidal behavior, or hallucinations. The project pays special attention to whether risks are higher when these sleep medicines are used alongside stimulant medications for ADHD. The goal is to produce information that helps doctors choose safer treatments for youth with ADHD and sleep problems.

Why it matters

Potential benefit: Could produce clearer guidance so clinicians and families choose safer sleep treatments and reduce serious side effects in children and teens with ADHD.

How similar studies have gone: There are few rigorous safety studies of these sleep medicines in children, so adult studies hint at risks but this project fills an important gap for youth-specific evidence.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Bushnell, Greta — Rutgers Biomedical and Health Sciences
  • Study coordinator: Bushnell, Greta

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.